Background: In hypertensive subjects, the ratio between ankle and brachial systolic blood pressure (ABI) has been shown to be an independent risk factor for cardiovascular diseases, particularly in the elderly. Plasma insulin may be an important interconnecting factor explaining this observation. Purpose: In a population of middle-aged subjects with essential hypertension and moderate overweight, we identified whether the decrease in the ABI ratio was associated with the clinical and biochemical factors involved in resistance to insulin. Patients with diabetes and/or arteriosclerosis obliterans of the lower limbs were excluded from the population. Subjects were or were not on antihypertensive therapy. Result: On the basis of univariate correlations, the ABI ratio was found to be significantly and negatively associated not only with the degree of abdominal fat distri-
Introduction
Abnormalities of glucose, insulin and lipids are common in patients with hypertension.
1,2 The higher plasma concentrations of glucose and insulin are known to result from the resistance of peripheral tissue to the action of insulin to stimulate glucose uptake. 1 Insulin resistance is more frequently observed in hypertensive patients who are overweight and the abdominal fat distribution than with those with normal weight and femoral fat distribution. [1] [2] [3] In patients with essential hypertension, insulin resistance may be exacerbated by antihypertensive drug therapy, mainly when diuretics and beta-blocking agents are involved. [4] [5] [6] [7] [8] Resistance to insulin is also a predictor of cardiovascular complications, particularly for the coronary circulation. 1, 5, 6, 9, 10 The ratio between ankle on brachial systolic blood pressure (ABI) is a well established index allowing bution, but also with the usual biological features of resistance to insulin: plasma triglycerides and cholesterol; plasma glucose and insulin; and plasminogen activator inhibitor (PAI) antigen. In a multivariate analysis in subjects with untreated hypertension, the ABI ratio was significantly and negatively associated with only three variables: age, plasma insulin and PAI antigen. In treated hypertensive subjects, only the role of age and insulin remained significant. Conclusion: Since the alterations of the ABI ratio may be considered as a marker of the changes in the structure and function of arteries of the lower limbs, the study provides evidence that plasma insulin and PAI antigen, independently of the presence of significant atherosclerotic occlusive lesions, are susceptible to alter the pressure wave transmission in conduit arteries of the lower limbs.
us to routinely detect arteriosclerosis obliterans of the lower limbs. [11] [12] [13] [14] [15] Below the value of 0.94, this ratio is considered to be a clear-cut indicator for arterial occlusion. More recently, the ABI ratio has been recognised to be per se an independent predictor of cardiac risk in subjects with systolic hypertension in the elderly. [16] [17] [18] However, the potential links of this marker with resistance to insulin has never been investigated. Because drug treatment of hypertension prevents cardiovascular complications but acts in a much larger extent on the cerebral than on the coronary circulation, 19 it is important to evaluate in subjects with hypertension the potential relationships between two different markers of cardiac risk: the presence of insulin resistance, and the alterations of the ABI ratio.
The purpose of the present study was, in a population of subjects with essential hypertension either treated or untreated: (i) to determine the relationship between the clinical and biological factors involved in insulin resistance and the alterations of the ABI ratio; and (ii) to determine whether such links are influenced by the drug treatment of hypertension.
Patients and methods

Patients
A total of 166 males and 101 females who were overweight and had mild-to-moderate essential hypertension were included in the study. They were selected in a population of 837 hypertensive subjects referred to Hospital Broussais, Paris, from January 1994 to January 1996 on the basis of the following criteria: (1) age ranged between 20 and 75 years, and (2) no woman was treated by oral contraception. In the overall population, 58 subjects were never treated and the remaining were under antihypertensive drug treatment (see below) for at least 2 years at the time of the study. All subjects were at their peak weight and maintaining their weight within 2-3 kg range on a stable caloric intake.
Patients were considered to have had sustained hypertension when they were followed on antihypertensive drug therapy or when diastolic pressure repeatedly measured by indirect method was superior or equal to 95 mm Hg during the untreated ambulatory period. Blood pressure determinations were performed using an appropriate pressure cuff, according to the arm circumference. 20 Investigations included determinations of blood and urinary electrolytes, urinary catecholamine metabolites, serum creatinine, blood glucose and plasma insulin (fasting and 2 h after meal), fasting plasma total cholesterol, triglyceride, high density lipoprotein (HDL) cholesterol levels and plasminogen activity inhibitory (PAI) factors according to classical methods. 21 Natriuresis was between 80 and 130 meq/day. On the basis of these investigations, all patients were considered to have essential hypertension. Menopause was observed in 54 women. No patients had congestive heart failure, cardiovascular accidents, arteriosclerosis obliterans of the lower limbs, renal or coronary insufficiency. Patients who had pregnancy, diabetes mellitus, hyperlipidaemia, cardiac disease, alcoholism, drug addiction or psychiatric problems were excluded from the study. Mean creatinine clearence rate was 97 ± 9 ml/min/1.73 cm 2 (±1 standard error of the mean) In the totality of patients, the diagnosis of overweight was based on determination of body mass index (weight/height 2 ) ranging from 25 to 30 according to NIH criteria. 22 No patient had severe obesity with fat and/or oedematous legs, which were then excluded from the study. Clinical characteristics of the population are detailed in Tables 1 and 2 . Antihypertensive monotherapy was present in 98 patients and bitherapy in 78 patients. Thirty-three subjects were treated by three antihypertensive agents or more. In treated hypertensive subjects, drugs included diuretics in 28% patients, betablocking agents in 43%, converting enzyme inhibitors in 40% and calcium entry blockers in 42%. The protocol was approved by the Institut National de la Santé et de la Recherche médicale (INSERM). Informed consent was obtained from all the patients after a detailed description of the procedure. 
Methods
After an overnight fast, patients were brought to the laboratory at 8 am. Body weight was determined without shoes. Only underclothes were kept on. Body height was measured with a metal height scale attached to the weight scale. Six cuff blood pressure determinations were performed within 1 h in the recumbent position after 10 min of rest. Blood pressure was the mean of these measurements. Abolition of Korotkoff sounds was used for the evaluation of diastolic blood pressure. Waist and hip circumferences were measured using a plastic tape. The subject being in a standing position and breathing normally, waist circumference was measured at the smallest waist circumference. The hip circumference was measured at its maximum. All anthropometric measurements were performed in duplicate by a single experimented observer. Body fat distribution was assessed by the ratio between the waist and the hip circumferences (WHR). The intra-individual reproducibility of the measurement was 8 ± 3%. 21 The normal values in obese and non-obese normotensive subjects were: in females aged for 30-40 years, 0.75 ± 0.02, and, in males aged for 30-40 years, 1.00 ± 0.02.
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In subjects in the supine position, brachial and ankle systolic arterial pressures were measured after 15 min rest on the right and left sides, by using a 331 pressure cuff of appropriate diameter, a standard mercury sphygmomanometer, and a Doppler probe, according to the technique described by Yao et al.
11
Brachial systolic pressure was recorded at the first appearance of an audible sound. Ankle systolic pressure was determined by a pressure cuff applied snugly above the malleolus. The cuff was inflated to a pressure exceeding the brachial systolic pressure by about 40 to 50 mm Hg. The end-point of the systolic pressure was determined by the reappearance of the pulse (an audible Doppler sound). In accordance with the requirements of this technique, none of the limbs presented an incompressible arterial syndrome. Three measurements were performed on each limb, and the mean value was taken as the ankle systolic pressure. The ankle on brachial index (ABI) ratio was then calculated. Subjects with an ABI ratio below 0.94 were excluded from the study. A complete Doppler investigation, which involved all the lower extremity arteries, from the iliac to the ankle arteries, did not detect any significant stenosis of the lower limbs in any of the 267 subjects. Total cholesterol and triglyceride were assayed by enzymatic method (Trinder Kit, Bio Mérieux, Marcy l'étoile, France). HDL cholesterol was measured after precipitations of very low density lipoprotein (VLDL) and LDL by a heparin manganese-reagent. For insulin, plasma was separated and frozen at −80°C until laboratory analysis was performed within 6 months. Insulinaemia was measured by radioimmunoassay (Kit Oris, Compagie Gris Industries, Gif sur Yvette, France). Intra-assay variability was from 5.3% for insulin. 23 For fibrinolysis assays, blood was anticoagulated on acidified citrate (Stabilyte, Biopool) for tissue-type plasminogen activator. Then PAI and t-PA activity (spectrolyse fibrin Biopool) and antigen (Tint Elize Biopool) were measured. 24 For statistical evaluation mean values are presented ±1 standard error of the mean. Univariate and multiple correlation analysis was performed using conventional methods. A P value below 0.05 was considered as significant.
Results
Description of the population
The characteristics of treated and untreated hypertensive subjects are presented in Tables 1 to 3 . Whereas the ABI ratio was identical in treated and untreated subjects, the latter had a higher age (P Ͻ 0.001), lower values of blood pressure (P Ͻ 0.001) ( Table 2 ) and higher values of plasma insulin (P Ͻ 0.05) ( Table 3) . PAI antigen was identical in both populations (Table 3) . Plasma insulin and PAI antigen were significantly correlated (P Ͻ 0.05) both in untreated (r = 0.26; slope 0.168; intercept 9.5) and treated (r = 0.27; slope 0.196; intercept 11.3) subjects.
Univariate correlations of the ABI ratio (Table 4)
In both populations (untreated and treated), the ABI ratio was negatively correlated to age (P Ͻ 0.01; P Ͻ 0.001) (Figure 1 ), WHR (P Ͻ 0.01 and P Ͻ 0.05), blood glucose (P Ͻ 0.05; P Ͻ 0.001) and insulin (P Ͻ 0.01) (Table 4, Figure 2 ).
The ABI ratio was also negatively correlated with total plasma cholesterol but the correlation was significant only in untreated subjects (P Ͻ 0.05). The ABI ratio was negatively correlated with PAI activity and antigen (P Ͻ 0.01) but only in untreated subjects (Table 4 ) (Figure 3) . The ABI ratio was not correlated with body weight, body mass index and brachial systolic blood pressure. The ABI ratio was negatively correlated with ankle systolic blood pressure (r = −0.14; P = 0.02).
Multivariate analysis of the ABI ratio
In Table 5 the multivariate analysis indicates that, in untreated subjects, only three factors significantly influenced the ABI index: age, plasma insulin and PAI antigen. In treated subjects as in the overall population (Table 6) , only age and plasma insulin remained significant predictors. Gender did not modify such findings.
Discussion
In the present study, we determined the ABI ratio in a large population of subjects with mild-to-moderate hypertension and moderate overweight. The main findings were: (i) the ABI ratio was negatively correlated with the usual clinical (abdominal fat distribution), and biological markers involved in insulin-resistance, and (ii) from these biological markers, only plasma insulin and PAI antigen modulated the ABI level in untreated subjects. The influence of PAI antigen was not observed in treated subjects. Such findings were noted even after adjustment for age and gender.
Considerations on the ABI ratio
A commonly used non-invasive test for peripheral arterial disease is the measurement of systolic blood 12 thus raising several methodological problems, [11] [12] [13] [14] [15] which involved: differences in geometry between the two ankle vessels; difference in pressures between the right and left legs; and the decrease in brachial arterial pressure over time which would result in the higher pressure occurring in the leg first measured. [11] [12] [13] [14] [15] 25, 26 For all these reasons, in the present study three measurements were performed on each artery of each limb after 15 min rest and the mean value was taken as the ankle systolic blood pressure. In recent years, the use of the ABI index to identify arterial stenosis of the vessels of the lower extremities in study subjects has been endorsed by the American Heart Association Council on Epidemiology. 27 Most research to date has indicated that when the resting ABI is 0.94 or higher, there is no anatomical evidence of arterial occlusion or incompressible syndrome. The sensitivity and specificity of the resting index for identification of occlusive disease is 96% or higher when compared with arteriography, thus excluding a major role for the presence of significant stenosis. In the present study, the totality of the population-based study has resting index of 0.94 or more and thus, this cut-off point may be considered as an effective indicator of absence of significant arterial occlusion. In that condition, the main problem of the study is to interpret that, in the studied population, systolic blood pressure was higher at the ankle than at the brachial artery and that some factors such as age and plasma insulin may influence this finding.
For a long time, studies of pulsatile arterial haemodynamics have shown that whereas mean arterial pressure remains practically constant along the arterial tree, pulse pressure increases significantly from central to peripheral arteries, due to a predominant increase in systolic blood pressure with a small decrease of diastolic blood pressure. 28 This haemodynamic pattern is the physiological consequence of the progressive stiffening and reduction in the calibre of large arteries, and also of the changes in the timing of reflected pressure waves inside the arterial tree. 28, 29 Indeed, the aortic blood pressure curve may be considered as the mathematical summation of an incident pressure wave, coming from the heart and propagating along the arterial tree, and a reflected wave, returning to the heart from reflection sites located at the origin of resistant vessels. The forward wave is influenced by the pattern of ventricular ejection and the degree of aortic stiffness. 28, 29 The amplitude and timing of the reflected wave depends not only on arterial stiffness, but also on the distance between the reflection sites and the heart, both factors making that ankle systolic blood pressure is physiologically higher than brachial systolic blood pressure. This haemodynamic pattern is largely influenced by age. In normal subjects of the middle age, arterial stiffening remains modest and reflection points are principally observed at the early narrowing of small resistant vessels, causing a return of reflection waves during the diastolic component of the aortic pressure wave with a relatively low aortic systolic and pulse pressure. 28, 29 This condition, which contributes to maintain the pulse pressure amplification along the arterial tree, explain that the ABI ratio may be superior to one, the distance between the heart and lower limbs being higher than that between the heart and upper limbs. 30 In older subjects, particularly those with hypertension, arterial stiffness increases markedly and additional reflecting sites operate closer to the heart, causing a return of reflected waves during the systolic component of pressure wave, with the apparition of a late systolic aortic peak. 28, 29 This mechanism is responsible for a higher increase in aortic systolic blood pressure than peripheral systolic pressure with age, leading to a loss in pulse pressure amplification and to identical values of systolic and pulse pressure in all the compartments of arterial tree. In this case, the ABI ratio becomes equal to 1.00. 30 Values between 0.94 and 1.00 in the absence of arterial occlusions are easily explained on the basis of the variability of the technique and have been discussed previously by others. [11] [12] [13] [14] [15] In the present study, our finding of a negative relationship between ABI and age ( Figure 1 ) concords with this general interpretation of the ABI ratio.
Taken together, these findings clearly indicate that factors which influence the ABI ratio, independently of arterial occlusions, are those which affect the structure and the function of large arteries, principally of the lower limbs, ie, the cross-sectional area and the length of these arteries, their thickness and the composition of the wall material, and, finally, the effects of endothelium function and vasomotor tone on vascular smooth muscle.
The ABI ratio and plasma insulin
A positive relationship between the degree of obesity and the level of brachial blood pressure has been widely reported in subjects with essential hypertension. 21 A weaker correlation has been observed between brachial systolic blood pressure and the fat distribution in obese and non-obese subjects. 7, 21, 31, 32 In the present study, we found that the degree of abdominal fat deposition was strongly associated with the decrease in ABI ratio. The validity of this relationship was based on two important findings: (i) the ABI ratio was no significantly correlated with body weight or body mass index, and (ii) the observed correlation did not result from a significant correlation between the WHR and brachial systolic blood pressure but rather from a negative correlation between the WHR and ankle systolic blood pressure. Finally, because the degree of abdominal obesity is known to be strongly associated with the presence of insulin resistance, 7, 12 we tried to correlate the ABI ratio with all the other major biological markers of resistance to insulin, ie, hypertriglyceridaemia, low HDL-cholesterol, hyperglycaemia and hyperinsulinaemia and finally PAI antigen. 1 Significant negative correlation coefficients were observed with each of these metabolic disorders, indicating that all these biological markers were significantly associated with the observed changes in pressure wave transmission of lower limbs.
The major finding of the present study was that the ABI ratio, although significantly associated with body fat distribution and all the well-established metabolic markers of resistance to insulin, was principally influenced by one factor: the level of plasma insulin. This new finding, which resulted from multiple regression analysis, was dependent on age, gender and on the presence or absence of antihypertensive drug treatment. Insulin is known to contribute to several pathophysiological mechanisms including glucose metabolism, renal sodium reabsorption and sympathetic nervous activity. However, the present study rather suggests the role of insulin on vascular growth and resulting changes in the structure and the function of the vessels. 1, 8, [33] [34] [35] [36] Indeed insulin receptors are present on arteries, particularly on the endothelium. 37, 38 Mitogenic effects of insulin on the arterial wall have been widely described [39] [40] [41] [42] and may influence the vascular structure and function, 43 thus affecting the arterial geometry, modifying reflection coefficients, and finally altering pressure wave transmission and the ABI ratio.
In this study, not only the role of insulin was identified, but also that of PAI antigen in subjects with untreated hypertension. Clinical studies have shown that decreased fibrinolytic activity is present in subjects with bordeline and sustained hypertension. [44] [45] [46] [47] It is widely accepted that the relationship between hypertension and fibrinolytic activity largely reflects the overall effect of the insulin resistance syndrome and does not reflect a direct effect of blood pressure. [44] [45] [46] [47] Treating insulin resistance with metformin reduces together the glucose disposal in response to insulin and the altered fibrinolytic activity. 48, 49 In the present study, although insulin and PAI antigen were significantly correlated, it seems likely that both insulin and PAI antigen influenced the ABI ratio, but only insulin played a significant role in treated subjects. Since the population was treated by various antihypertensive agents, further studies are needed to clarify the druginduced links between the ABI and PAI antigen. 50 In conclusion, the present study has shown that, in subjects with hypertension and moderate overweight, the lowering of the ABI ratio should not be constantly related to the presence or absence of significant stenosis and/or thrombosis of the lower limbs but also may reflect alterations in pressure wave transmission and pulse pressure amplification. This disturbance is strongly influenced by the presence of resistance to insulin. Plasma insulin and PAI antigen were identified for the first time as major factors contributing to modulate the ABI ratio in subjects with hypertension.
